Varian receives FDA 510(k) for single-channel HDR brachytherapy afterloader

TriMed Staff | | Health Imaging | Diagnostic Imaging
The FDA has cleared Varian Medical Systems Inc.'s new single-channel device for delivering High-Dose Rate (HDR) brachytherapy.

Varian's MammoSource afterloader is a computer-controlled device that delivers a high-energy radioactive source through a single catheter, into the cavity left when a tumor has been surgically removed. It works with Varian's BrachyVision software, an image-guided HDR brachytherapy treatment planning system.

William Hyatt, vice president and general manager of Varian's Brachytherapy business, said the single-channel system is "specifically engineered for these single catheter treatments and is designed to reduce the capital cost barriers often faced by hospitals wishing to offer the new accelerated breast brachytherapy techniques."

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup